Download full-text PDF

Source
http://dx.doi.org/10.1097/MJT.0000000000000834DOI Listing

Publication Analysis

Top Keywords

tenofovir alafenamide-induced
4
alafenamide-induced renal
4
renal tubular
4
tubular acidosis
4
tenofovir
1
renal
1
tubular
1
acidosis
1

Similar Publications

Successful Treatment of Tenofovir Alafenamide-Induced Lactic Acidosis: A Case Report.

J Pharm Pract

October 2023

Department of Medicine, Division of Gastroenterology & Hepatology - NYU Langone Health, New York, NY, USA.

Nucleoside or nucleotide analogues (NAs) have the potential to cause lactic acidosis by inhibiting DNA polymerase-γ of human mitochondria and impairing aerobic metabolism. Patients may be asymptomatic, have mild non-specific symptoms, or present in multisystem organ failure. There is a paucity of data to guide management of life-threatening lactic acidosis due to NA therapy.

View Article and Find Full Text PDF

We report here the case of a 32-year-old male with recent diagnosis of HIV that, 45 days after starting a single tablet regimen co-formulated with bictegravir, emtricitabine and tenofovir alafenamide (BIC/FTC/TAF), experienced severe epigastric pain radiating to the back, nausea, episodes of non-bloody non-bilious vomiting and anorexia. Laboratory examination showed a rise in lipase with no alterations in serum transaminases. Abdominal ultrasound revealed a non-homogeneous structure of the pancreatic parenchyma.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!